The boss of AstraZeneca could earn £18.5m this year - but he may be underpaid

The drugmaker was on its knees when Sir Pascal Soriot took over in 2012. But under his leadership it now does just about everything the UK wants from a business - creating high value-added jobs and developing products that improve people's lives.

Related Keywords

Switzerland ,United Kingdom ,Florida ,United States ,London ,City Of ,Denmark ,Cambridge ,Cambridgeshire ,Norway ,Israel ,Britain ,Israeli ,American ,David Ricks ,Albert Bourla ,Pascal Soriot ,Eli Lilly ,Rajiv Jain ,Richard Gonzalez ,Liverpool Mo Salah ,Novo Nordisk ,Norges Bank Investment Management ,London Stock Exchange ,University Of Oxford ,Glaxosmithkline ,Pfizer ,Astrazeneca ,Reckitt Benckiser ,Sir Pascal ,United Kingdom Listed ,Glass Lewis ,Financial Times ,Bank Investment Management ,Manchester City ,Kevin De Bryne ,Manchester United ,Premier League ,